BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 53 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,344,000 | +1.2% | 5,001,000 | +0.0% | 0.01% | +33.3% |
| Q4 2019 | $5,282,000 | +7.5% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $4,915,000 | -5.3% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $5,191,000 | +1.5% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $5,116,000 | +2.9% | 5,000,000 | 0.0% | 0.01% | -14.3% |
| Q4 2018 | $4,972,000 | -6.7% | 5,000,000 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $5,329,000 | -98.9% | 5,000,000 | 0.0% | 0.01% | -98.9% |
| Q2 2018 | $505,100,000 | +7.6% | 5,000,000 | 0.0% | 0.56% | +4.1% |
| Q1 2018 | $469,375,000 | – | 5,000,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |